Perrigo (PRGO) Long-Term Investments (2013 - 2020)
Perrigo (PRGO) posted quarterly Long-Term Investments of $121.2 million for Q3 2020, up 32.17% year-over-year from $91.7 million in Q3 2019, and up 22.42% quarter-over-quarter from $99.0 million in Q2 2020.
Perrigo (PRGO) Long-Term Investments (2013 - 2020) Analysis & Trends
Perrigo (PRGO) has reported Long-Term Investments for 7 consecutive years, with $121.2 million the latest figure, recorded in Q3 2020.
- In Q3 2020, Long-Term Investments rose 32.17% year-over-year to $121.2 million; the TTM figure through Sep 2020 stood at $121.2 million (up 32.17% YoY), while the FY2019 annual figure was $95.3 million, down 70.51% from the prior year.
- Long-Term Investments improved to $121.2 million in Q3 2020 per PRGO's latest filing, from $99.0 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $3.6 billion in Q2 2016 and bottomed at $83.6 million in Q1 2019.
- Historically, Long-Term Investments has averaged $364.4 million across 5 years, with a median of $124.9 million in 2018.
- Annual changes were most pronounced in 2017 — Long-Term Investments sank 94.8% — and 2018, when it surged 140.3%.
- Perrigo's Long-Term Investments stood at $3.6 billion in 2016, then sank by 96.21% to $134.5 million in 2017, then soared by 140.3% to $323.2 million in 2018, then slumped by 70.51% to $95.3 million in 2019, then advanced by 27.18% to $121.2 million in 2020.
- Business Quant data shows PRGO's Long-Term Investments at $121.2 million in Q3 2020, $99.0 million in Q2 2020, and $96.9 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 60.00 Mn |
| 10 | Perrigo | 1.98 Bn | 1.58 Bn | 313.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 26, 2020 | 121.20 Mn |
| Jun 27, 2020 | 99.00 Mn |
| Mar 28, 2020 | 96.90 Mn |
| Dec 31, 2019 | 95.30 Mn |
| Sep 28, 2019 | 91.70 Mn |
| Jun 29, 2019 | 89.10 Mn |
| Mar 30, 2019 | 83.60 Mn |
| Dec 31, 2018 | 323.20 Mn |
| Sep 29, 2018 | 200.40 Mn |
| Jun 30, 2018 | 125.50 Mn |
| Mar 31, 2018 | 124.90 Mn |
| Dec 31, 2017 | 134.50 Mn |
| Jul 1, 2017 | 145.80 Mn |
| Apr 1, 2017 | 184.50 Mn |
| Apr 2, 2016 | 3.55 Bn |
| Mar 29, 2014 | 60.60 Mn |
| Dec 28, 2013 | 69.00 Mn |
| Jun 29, 2013 | 4.40 Mn |